15.37
Oruka Therapeutics Inc Aktie (ORKA) Neueste Nachrichten
Oruka Therapeutics (NASDAQ:ORKA) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
What makes Oruka Therapeutics Inc. stock price move sharplyMarket Growth Report & Fast Momentum Stock Entry Tips - Newser
What is the Moat Score of Oruka Therapeutics Inc.Quarterly Performance Summary & Fast Momentum Stock Entry Tips - thegnnews.com
Why Oruka Therapeutics Inc. stock attracts strong analyst attentionMarket Activity Summary & Free High Return Stock Watch Alerts - Newser
Leerink Partnrs Has Pessimistic View of ORKA Q3 Earnings - Defense World
Has Oruka Therapeutics Inc. found a price floorPortfolio Return Summary & Daily Entry Point Trade Alerts - Newser
How to build a custom watchlist for Oruka Therapeutics Inc.2025 Price Targets & Low Risk Growth Stock Ideas - Newser
What Fibonacci levels say about Oruka Therapeutics Inc. reboundJuly 2025 Gainers & Safe Capital Growth Stock Tips - Newser
Oruka Therapeutics Inc. stock trendline breakdownJuly 2025 Final Week & Capital Protection Trading Alerts - Newser
Technical analysis overview for Oruka Therapeutics Inc. stockJuly 2025 Intraday Action & Accurate Trade Setup Notifications - Newser
Smart tools for monitoring Oruka Therapeutics Inc.’s price actionTrade Volume Summary & Consistent Profit Alerts - Newser
Custom watchlist performance reports with Oruka Therapeutics Inc.Earnings Growth Report & Community Trade Idea Sharing - Newser
Published on: 2025-08-13 20:29:16 - beatles.ru
Oruka Therapeutics Inc.’s volatility index tracking explained2025 Price Targets & Low Drawdown Investment Strategies - Newser
Oruka Therapeutics’ (ORKA) Outperform Rating Reaffirmed at Wedbush - Defense World
Long term hold vs stop loss in Oruka Therapeutics Inc.Automated AI Forecast with Trading Alerts - Newser
Oruka Therapeutics stock maintains Buy rating at BTIG on promising psoriasis treatments - Investing.com Canada
Oruka Therapeutics Reports Q2 2025 Financial Results - TipRanks
How high can Oruka Therapeutics Inc. stock price go in 2025Free Entry Alert Based on Volume Spikes - Newser
Oruka Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Oruka Therapeutics Shares Climb After FDA Greenlights Psoriasis Drug Trial - MSN
Oruka's Novel Psoriasis Drug Enters Phase 2a: Potential Yearly Dosing Could Transform Treatment Landscape - Stock Titan
Published on: 2025-08-10 17:56:29 - beatles.ru
RSI + MACD Show Convergence for Oruka Therapeutics Inc.Reliable Alerts for Daily Stock Movers Released - metal.it
Published on: 2025-08-10 12:04:33 - metal.it
Published on: 2025-08-10 04:46:39 - Newser
Oruka Therapeutics Inc. Inches Above Key Support — Safe to HoldLow Risk High Return Opportunities Identified - metal.it
How Oruka Therapeutics Inc. stock performs during market volatilityFree Early Entry Tips With Low Risk Zone - Newser
Published on: 2025-08-09 01:24:57 - Newser
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Average Recommendation of “Buy” from Analysts - Defense World
How to integrate Oruka Therapeutics Inc. into portfolio analysis toolsEarnings Report Summary with Market Impact - Newser
Can technical indicators confirm Oruka Therapeutics Inc.’s reversalWeekly Movement Forecast With Chart Signals - Newser
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):